EUVIMEDEUVIMED entdecken
Crossref

L26/P-420 Who returns to use their eggs? Factors associated with oocyte utilization after medical fertility preservation

C. Felicioli, C. Sonigo, M. Grynberg, F. Eustache, C. Sifer, M. Peigné

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.754 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von C. Felicioli und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question What are the predictors of vitrified oocyte utilization after medical fertility preservation? Summary answer Increased oocyte utilization was associated with age and diminished ovarian reserve at cryopreservation, while prior parity and low oocyte yield were linked to reduced rates. What is known already Data regarding oocyte utilization following medical fertility preservation are scarce. While existing studies report consistently low utilization rates, these rates appear higher in non-oncological indications compared to oncological ones. To date, no study has specifically investigated the predictive factors of oocyte utilization in a medical setting. Conversely, in the context of elective fertility preservation, reported predictors of utilization include a low number of vitrified oocytes and advanced age (>38 years). Study design, size, duration This retrospective, observational, single-center study included 1,787 women who underwent oocyte cryopreservation for medical fertility preservation at the Department of Reproductive Medicine, Jean Verdier University Hospital (Bondy, France), from January 1, 2013, to December 31, 2021. Participants/materials, setting, methods Women undergoing oocyte cryopreservation after controlled ovarian stimulation or in vitro maturation for medical fertility preservation were included. Clinical, biological and socio-demographic characteristics recorded at cryopreservation were analysed, including age, ovarian reserve, reproductive history and preservation indication. Oocyte utilization was assessed until December 31, 2024. Women were compared according to utilization status. Cumulative incidences were estimated, and predictive factors were identified using Cox models. Post-warming outcomes were evaluated according to indication and age at follow-up. Main results and the role of chance Among the 1,787 patients included, 60% had benign indications (primarily endometriosis) and 40% had malignant indications (predominantly breast cancer and hematologic malignancies). During the study period, 254 women (14.2%) returned to use their oocytes. The cumulative incidence of utilization reached 19.3% (95% CI [17.4–21.9%]) at 8 years post-cryopreservation. This rate was significantly higher among women aged >36 years, those with diminished ovarian reserve, and those with benign indications. Descriptive analysis showed that users were older at cryopreservation, had lower ovarian reserve markers, and belonged to a higher socio-economic status. In multivariable Cox regression, age >36 years (HR 2.1) and AMH levels <1.2 ng/mL (HR 1.58) were independently associated with increased utilization. Conversely, prior parity (HR 0.67) was associated with reduced use, as was a low oocyte yield (<7; HR 0.7). Subgroup analyses by indication showed similar trends. Of the users, 227 returned to our center, where 2,995 oocytes were warmed, resulting in 71 live births. The live birth rate per warmed oocyte was 1.4% for IVM and 2.5% for ovarian stimulation, irrespective of age or indication. Limitations, reasons for caution The main limitations of this study are its retrospective and single-centre design. In addition, heterogeneous follow-up duration may limit the assessment of oocyte utilization in some younger women who had not yet initiated their reproductive project. Wider implications of the findings Identifying factors associated with the utilization of vitrified oocytes will improve counselling during medical fertility preservation consultations and support shared decision-making. Trial registration number No

Zitieren

APA

Felicioli, C., Sonigo, C., Grynberg, M., Eustache, F., Sifer, C., & Peigné, M. (2026). L26/P-420 Who returns to use their eggs? Factors associated with oocyte utilization after medical fertility preservation. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.754

Vancouver

Felicioli C, Sonigo C, Grynberg M, Eustache F, Sifer C, Peigné M. L26/P-420 Who returns to use their eggs? Factors associated with oocyte utilization after medical fertility preservation. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.754

BibTeX
@article{Felicioli2026,
  author = {Felicioli, C. and Sonigo, C. and Grynberg, M. and Eustache, F. and Sifer, C. and Peigné, M.},
  title = {L26/P-420 Who returns to use their eggs? Factors associated with oocyte utilization after medical fertility preservation},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.754}
}
Kostenlos starten →